自三十年前聚二甲基硅氧烷消泡剂在医药产品中出现以来,有机硅化合物作为人类医疗剂已日益受到人们的注意。由于聚二甲基硅氧烷的临床用途较广、毒性较小,故已为医药界所接受,并被载入中、美、英、日、加等国家药典。随着有机硅化学的迅速发展,围绕有机硅化合 Since the appearance of polydimethylsiloxane defoamers in pharmaceutical products three decades ago, organosilicon compounds have gained increasing attention as human medical agents. As the polydimethylsiloxane has a wide range of clinical uses and less toxicity, it has been accepted by the pharmaceutical industry and is loaded into the national pharmacopoeias of China, the United States, Britain, Japan, Canada and the like. With the rapid development of silicone chemistry, around the silicone compound